thrombocytopenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients undergoing interventional operation through femoral artery puncture; (2) Age 18-90 years old, gender unlimited; (3) Patients with thrombocytopenia, platelet count less than 100×10^9/L; (4) Expected survival >= 3 months; (5) Understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who cannot receive interventional treatment; (2) Prolonged ATPP/PT/TT, otherwise prone to delayed bleeding (3) Active severe clinical infection (> Grade 2, NCI-CTCAE version 4.0) within 14 days prior to enrollment, including active tuberculosis; (4) Known or self-reported HIV infection; (5) uncontrolled systemic diseases, such as poorly controlled diabetes; (6) known hypersensitivity or allergic reaction to any component of the investigational drug; (7) any condition that the investigator determines to be unstable or likely to compromise the subject's safety and compliance with the study; Comorbidities or social circumstances that could prevent subjects from following the study plan or even endanger patient safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compression hemostatic time;No hematoma was found; | — |
Secondary
| Measure | Time frame |
|---|---|
| vascular complication;Local complication;Local ecchymosis; | — |
Countries
China
Contacts
West China Hospital of Sichuan University